News
Academy
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Latest Executive Roundtables
  • Asembia 2025
  • Sales Effectiveness
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe
Advertisement

Industry Trends

>
  • IR Licensing and Partnerships

Latest News

CSL to Layoff 15% of Employees, Close 22 US-based Plasma Centers
CSL to Layoff 15% of Employees, Close 22 US-based Plasma Centers
By Don Tracy, Associate Editor

August 19th 2025

The global biotherapeutics company announced that it will seek to streamline operations as part of a broader transformation to boost efficiency, refocus on core businesses, and reinvest in high-priority programs.

Layoffs Continue Across Biotech Industry as More Companies Restructure and Reprioritize
Layoffs Continue Across Biotech Industry as More Companies Restructure and Reprioritize
By Don Tracy, Associate Editor

August 14th 2025

Fate Therapeutics, Generation Bio, and ORIC Pharmaceuticals join a growing list of companies implementing workforce reductions as they restructure operations, extend cash runways, and focus resources on advancing lead clinical programs amid challenging market conditions.

AbbVie Latest to Commit to New US Manufacturing Growth Projects, Committing $195 Million to Expand API Capabilities
AbbVie Latest to Commit to New US Manufacturing Growth Projects, Committing $195 Million to Expand API Capabilities
By Don Tracy, Associate Editor

August 13th 2025

The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and oncology medicines, with construction beginning in 2025 and operations slated for 2027.

Bayer Layoffs Reach 12,000 in Ongoing $2.3 Billion Restructuring Plan
Bayer Layoffs Reach 12,000 in Ongoing $2.3 Billion Restructuring Plan
By Don Tracy, Associate Editor

August 7th 2025

The company is streamlining its global workforce as part of a multi-year cost-cutting strategy, while raising its 2025 outlook on the strength of key pharmaceutical products.

Stephanie J. Creary, Assistant Professor of Management at The Wharton School of The University of Pennsylvania.
How Should BioPharma C-Suites Guide and Support Remaining Employees After Workforce Reductions?
By Michael Wong

August 5th 2025

A Harvard Business School Healthcare Alumni Association Q&A with Stephanie J. Creary, Assistant Professor of Management at The Wharton School of The University of Pennsylvania.

More News


The Open, Closed, and Exploding World of Research Data

The Open, Closed, and Exploding World of Research Data

Oracle
August 29th 2023

Webinar Date/Time: Tue, Oct 17, 2023 10:00 AM EDT | 9:00 AM CT | 3:00 PM BST | 4:00 PM CEST


Accelerating precision oncology with artificial intelligence

Accelerating precision oncology with artificial intelligence

Oracle
August 24th 2023

Webinar Date/Time: Tue, Sep 26, 2023 10:00 AM EDT | 9:00 AM CT | 3:00 PM BST | 4:00 PM CEST


Meg Rivers

Democratizing Insight

Meg Rivers
August 6th 2023

Here at Pharmaceutical Executive®, we are already planning our editorial calendar for 2024. And each year we go through this process, I consider this a time of reflection to see where the industry has come, what topics always seem to be on the tips of everyone’s tongues, and what should be a topic of focus. Along with artificial intelligence (AI) being top of mind, other topics that come into my inbox again and again relate to diversity, equity, and inclusion (DE&I) and addressing unmet medical needs.


2022 Prescription Trends

2022 Prescription Trends

Jamie Pritchett
May 22nd 2023

The market for prescription medicines in the United States was subject to major shifts in use across therapeutic areas in 2022, reflecting changes in patient health needs, the development, and availability of novel medicines, and complex market dynamics.


Forecasting in an Uncertain World

Forecasting in an Uncertain World

IQVIA
April 20th 2023

Webinar Date/Time: Thu, May 18, 2023 11:00 AM EDT


Better Inform Clinical Development Decisions Leveraging AI/ML-Powered Analytics

Better Inform Clinical Development Decisions Leveraging AI/ML-Powered Analytics

IQVIA
April 20th 2023

Webinar Date/Time: Wednesday, May 24th, 2023 at 10am EDT | 7am PDT | 3pm BST | 4pm CEST


Kevin Hagan, president and CEO PAN Foundation | image from video.

What Can Pharma Do for Patients Post IRA?

April 11th 2023

Kevin Hagan, president and CEO of the PAN Foundation, discusses how pharma can help Medicare patients post-IRA reform.


An Industry View on KOLs: Adapting to the New Norm in Interaction and Support

An Industry View on KOLs: Adapting to the New Norm in Interaction and Support

Mike Hollan
April 11th 2023

After the pandemic forced fundamenta­l­­­­ changes in the ways pharma and key opinion leaders worked together, both groups are using what they learned for a more seamless connection.


Sunil Verma, SVP, AstraZeneca Image Credit: from video

Pharma USA 2023: Changes to the Medical Affairs Function

April 7th 2023

Sunil Verma, SVP, Global Head of Oncology, Medical, AstraZeneca discusses how the Medical Affairs role will become more strategic and effective with data.


Kevin Hagan speaks about Medicare reform for patients: image from video

Pharma USA 2023: What Medicare Reform Means to Patient Access Network Foundation

April 7th 2023

Kevin Hagan, president and CEO of the PAN Foundation, spoke to PharmExec about the recent IRA changes that impact Medicare, as well as the Foundation's near-term goals.


Kevin Fagan: screen shot of video.

Pharma USA 2023: IRA Impact on Patients

April 5th 2023

Kevin Hagan, president and CEO of the PAN Foundation, spoke to PharmExec about the recent IRA changes to Medicare and how it positively effects patients.


DNA helix colorful genes chromosomes DNA sequence | Image credit:© catalin - stock.adobe.com.

CGT: Collaborate to Scale

Lisa Henderson
March 30th 2023

At Pharma USA 2023, Peter Marks, MD, PhD and director of CBER described FDA and public/private partnerships working toward scalable manufacturing approaches to address commercial viability and global access for cell and gene therapies


Harietta Eleftherochorinou

Navigating Disruption in the Metapharma Era

Harietta Eleftherochorinou
March 10th 2023

As the life sciences industry enters this next stage of growth, capitalizing on AI and digital transformation will be key to propelling innovation and ensuring that companies are prepared to tackle the challenges ahead.


Mike Hollan

A New Era of Influence: Embracing the KOL-DOL Dynamic in Healthcare

Mike Hollan
March 10th 2023

How pharma companies can leverage the lessons learned during the pandemic around key opinion leaders and digital opinion leaders, respectively, to best use new channels of communication. Can both coexist across the healthcare engagement spectrum?


The Personalized Patient Journey: A New Standard of Patient Centricity

The Personalized Patient Journey: A New Standard of Patient Centricity

VMS Biomanufacturing
February 21st 2023

Webinar Date/Time: Wed, Apr 12, 2023 1:00 PM EDT


Living Up to Its Promise: Can Omnichannel Deliver the ROI Pharma Needs to Keep Investing?

Living Up to Its Promise: Can Omnichannel Deliver the ROI Pharma Needs to Keep Investing?

Eversana
February 17th 2023

Webinar Date/Time: Mon, Mar 13, 2023 11:00 AM EDT


Confronting a Challenging Macroeconomic Environment with Innovation

Confronting a Challenging Macroeconomic Environment with Innovation

PwC
February 13th 2023

Webinar Date/Time: Thu, Mar 16, 2023 11:00 AM EDT


Site Logo

Why Program Management is the Key to Success for Life Science Companies

Carolina Ahrendt;Pam Wilson;Julia Libunao
February 6th 2023

Delivering value with enterprise program management.


Key Factors Attributing to a Successful  Product Launch

Key Factors Attributing to a Successful Product Launch

Christopher Savage
January 11th 2023

What the c-suite should consider in today’s marketplace.


Sales-Rep Compensation: Adding Long-Term Incentives to Mix

Sales-Rep Compensation: Adding Long-Term Incentives to Mix

Rohit Gupta
January 11th 2023

As they are forced to do more with less, pharma commercial leaders should rethink their incentive programs to ensure their sales teams remain strong drivers of growth.


Co-creating New Innovations

Co-creating New Innovations

Mike Hollan
January 11th 2023

Pharma companies are teaming with academic institutions earlier in the R&D process.


The Potential Impact of the IRA

The Potential Impact of the IRA

Lisa Henderson
January 11th 2023

Interpreting what the Inflation Reduction Act could mean for biopharma.


Patient Hubs Continue Growth

Patient Hubs Continue Growth

Meg Rivers
January 11th 2023

How technology will play a big role in advancing pharma approaches in patient support.


Social Media’s Complex Climb

Social Media’s Complex Climb

Francis Pollaro
January 11th 2023

As new channels enter healthcare conversation mix, engagement strategies are changing.


Industry Workforce Seeks Clarity

Industry Workforce Seeks Clarity

Andy Studna
January 11th 2023

An evolving job market has forced life sciences companies to respond.


Cybersecurity Threats & Pharma

Cybersecurity Threats & Pharma

Meg Rivers
January 11th 2023

The steps companies can take now to better protect themselves and their data.


Kelly Baker

Q&A with Kelly Baker, CFO of Eversana

Pharmaceutical Executive Editorial Staff
January 4th 2023

Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.


Site Logo

The Top Personalized Medicine Stories of the Year

Pharmaceutical Executive Editorial Staff
December 29th 2022

Personalized medicine continued its growth over the past year and became one of the most talked about topics in the life sciences industry.


Alan Kalton

Industry Predictions For 2023

Alan Kalton;David Ehrlich;Dr. Deepak Patil;Joel Morse;Dave Hanaman;Sanskriti Thakur
December 28th 2022

Top industry experts weigh in on what the new year holds for the pharma industry.


Site Logo

The Top 5 Stories of the Year

Pharmaceutical Executive Editorial Staff
December 27th 2022

Over the past year, the life sciences industry has experienced a variety of important innovations, while also facing an unstable economy. These factors were clearly on readers minds and helped shape the top stories of the year.

<12345678910
...
18>
About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.